VividFlo System Validation Study

Sponsor
VividWhite Pty Ltd
Study ID
NCT07754201
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • VividFlo System — DEVICE
    Subconjunctival surgical implantation of the VividFlo Glaucoma Implant (VW-51) in one eye using the VividFlo System and a partial-thickness scleral flap technique.

Study Details

This is a 10-participant study to assess the VividFlo System and surgical implantation using a modified technique.

Key Dates

First listed
Aug 10, 2026
Start date
Aug 10, 2026
Status verified
Aug 2026
Primary completion
Dec 31, 2027
Completion
Mar 31, 2028

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: VividFlo System
    Surgical implantation of VividFlo.

Primary Outcome Measure

Primary Outcome [ Time Frame: 12 months ]

Central Contacts

Find similar trials

Nationwide
Glaucoma trialsOphthalmology trials

Related Studies